GlassScriptPhysician profile
Mohamed Mohamed
NPI 1861742751
$10,505.35
in general payments reported to CMS, 2019-2025
34 companies · $1,688 in 2025
The $1,688 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $174 · 2021: $867 · 2022: $207 · 2023: $3,071 · 2024: $3,680 · 2025: $1,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,324 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,323.68 |
| Education | $114.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,531.27 | 2019-2025 | |
| Amgen INC. | $2,416.91 | 2019-2025 | Tavneos, Enbrel, Otezla |
| Astrazeneca Pharmaceuticals LP | $829.11 | 2023-2025 | Saphnelo |
| Janssen Biotech, INC. | $737.64 | 2022-2025 | Tremfya, Simponi Aria, Remicade |
| Novartis Pharmaceuticals Corporation | $612.11 | 2019-2025 | |
| Emd Serono, INC. | $514.62 | 2019-2021 | |
| Ucb, INC. | $474.15 | 2019-2025 | Cimzia, Bimzelx |
| Lilly USA, LLC | $416.27 | 2019-2025 | Taltz, Omvoh |
| Fresenius Kabi USA, LLC | $289.56 | 2023-2024 | Idacio |
| Pfizer INC. | $223.25 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $202.10 | 2019-2025 | Orencia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.34 | 2021-2024 | Cyltezo, Ofev |
| Mallinckrodt Enterprises LLC | $149.19 | 2019 | |
| Sobi, INC | $121.20 | 2022-2025 | |
| Genentech USA, INC. | $97.28 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $90.87 | 2024 | Arcalyst |
| Celgene Corporation | $76.08 | 2019 | |
| Organon LLC | $66.94 | 2024-2025 | Hadlima, Renflexis |
| Alexion Pharmaceuticals, INC. | $60.16 | 2023-2024 | Strensiq, Ultomiris |
| Radius Health, INC. | $55.52 | 2019-2024 | Tymlos |
| Mallinckrodt Hospital Products INC. | $50.62 | 2020-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $44.91 | 2019 | |
| Biocryst US Sales Co., LLC | $39.05 | 2024 | Orladeyo |
| Horizon Therapeutics Plc | $37.53 | 2019 | |
| Sandoz INC. | $33.21 | 2024 | Hyrimoz |
| Grifols USA, LLC | $26.83 | 2024 | Xembify |
| Actelion Pharmaceuticals US, INC. | $24.58 | 2024 | Opsumit |
| Janssen Pharmaceuticals, INC | $23.16 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $21.40 | 2023 | Arcalyst |
| Alvogen INC | $18.06 | 2023 | Teriparatide |
| Cycle Pharmaceuticals INC | $17.06 | 2024 | Sajazir |
| Glaxosmithkline, LLC. | $16.06 | 2023 | Nucala |
| Depuy Synthes Sales INC. | $14.17 | 2024 | Orthovisc, Monovisc |
| Alk-Abello, INC | $14.14 | 2023 | Grastek, Ragwitek, Odactra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.